These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 22640830)

  • 1. All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway.
    Lim YC; Kang HJ; Kim YS; Choi EC
    Eur J Cancer; 2012 Nov; 48(17):3310-8. PubMed ID: 22640830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigallocatechin-3-gallate attenuates head and neck cancer stem cell traits through suppression of Notch pathway.
    Lee SH; Nam HJ; Kang HJ; Kwon HW; Lim YC
    Eur J Cancer; 2013 Oct; 49(15):3210-8. PubMed ID: 23876835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4.
    Lee SH; Koo BS; Kim JM; Huang S; Rho YS; Bae WJ; Kang HJ; Kim YS; Moon JH; Lim YC
    J Pathol; 2014 Sep; 234(1):99-107. PubMed ID: 24871033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular characteristics of head and neck cancer stem cells in type IV collagen-coated adherent cultures.
    Lim YC; Oh SY; Kim H
    Exp Cell Res; 2012 Jun; 318(10):1104-11. PubMed ID: 22426199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cell mediated acquired chemoresistance in head and neck cancer can be abrogated by aldehyde dehydrogenase 1 A1 inhibition.
    Kulsum S; Sudheendra HV; Pandian R; Ravindra DR; Siddappa G; R N; Chevour P; Ramachandran B; Sagar M; Jayaprakash A; Mehta A; Kekatpure V; Hedne N; Kuriakose MA; Suresh A
    Mol Carcinog; 2017 Feb; 56(2):694-711. PubMed ID: 27380877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits.
    Oh SY; Kang HJ; Kim YS; Kim H; Lim YC
    Eur J Cancer; 2013 Jan; 49(1):272-80. PubMed ID: 22770891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cRGD peptide installation on cisplatin-loaded nanomedicines enhances efficacy against locally advanced head and neck squamous cell carcinoma bearing cancer stem-like cells.
    Miyano K; Cabral H; Miura Y; Matsumoto Y; Mochida Y; Kinoh H; Iwata C; Nagano O; Saya H; Nishiyama N; Kataoka K; Yamasoba T
    J Control Release; 2017 Sep; 261():275-286. PubMed ID: 28666729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [All-trans retinoic acid effectively inhibits breast cancer stem cells growth in vitro].
    Zeng WG; Hu P; Wang JN; Liu RB
    Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):89-93. PubMed ID: 23714660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of targeted therapy on recruited cancer stem cells in a head and neck carcinoma model.
    Marcu LG; Marcu D
    Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28857306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WM130 preferentially inhibits hepatic cancer stem-like cells by suppressing AKT/GSK3β/β-catenin signaling pathway.
    Ni CX; Qi Y; Zhang J; Liu Y; Xu WH; Xu J; Hu HG; Wu QY; Wang Y; Zhang JP
    Oncotarget; 2016 Nov; 7(48):79544-79556. PubMed ID: 27783993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth.
    Nguyen PH; Giraud J; Staedel C; Chambonnier L; Dubus P; Chevret E; Bœuf H; Gauthereau X; Rousseau B; Fevre M; Soubeyran I; Belleannée G; Evrard S; Collet D; Mégraud F; Varon C
    Oncogene; 2016 Oct; 35(43):5619-5628. PubMed ID: 27157616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.
    Zhao Z; Wang H; Zhang L; Mei X; Hu J; Huang K
    Anticancer Drugs; 2017 Feb; 28(2):187-196. PubMed ID: 27831944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
    Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
    Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-Met pathway promotes self-renewal and tumorigenecity of head and neck squamous cell carcinoma stem-like cell.
    Lim YC; Kang HJ; Moon JH
    Oral Oncol; 2014 Jul; 50(7):633-9. PubMed ID: 24835851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids.
    Wan H; Oridate N; Lotan D; Hong WK; Lotan R
    Cancer Res; 1999 Jul; 59(14):3518-26. PubMed ID: 10416619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of CD44 sensitizes cisplatin-resistance and affects Wnt/β-catenin signaling in HNSCC cells.
    Roy S; Kar M; Roy S; Padhi S; Kumar A; Thakur S; Akhter Y; Gatto G; Banerjee B
    Int J Biol Macromol; 2020 Apr; 149():501-512. PubMed ID: 31953176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RXRα-enriched cancer stem cell-like properties triggered by CDDP in head and neck squamous cell carcinoma (HNSCC).
    Jiang P; Xu C; Zhou M; Zhou H; Dong W; Wu X; Chen A; Feng Q
    Carcinogenesis; 2018 Feb; 39(2):252-262. PubMed ID: 29228308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-trans retinoic acid modulates bone morphogenic protein 9-induced osteogenesis and adipogenesis of preadipocytes through BMP/Smad and Wnt/β-catenin signaling pathways.
    Liu Y; Liu Y; Zhang R; Wang X; Huang F; Yan Z; Nie M; Huang J; Wang Y; Wang Y; Chen L; Yin L; He B; Deng Z
    Int J Biochem Cell Biol; 2014 Feb; 47():47-56. PubMed ID: 24300824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interplay between EZH2/β-catenin in stemness of cisplatin-resistant HNSCC and their role as therapeutic targets.
    Milan TM; Eskenazi APE; Oliveira LD; Silva GD; Bighetti-Trevisan RL; Freitas GP; Almeida LO
    Cell Signal; 2023 Sep; 109():110773. PubMed ID: 37331417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.